Literature DB >> 32303411

Serum total carbon dioxide as a prognostic factor for 28-day mortality in patients with sepsis.

Jin Hee Kim1, Dong-Hyun Jang2, You Hwan Jo3, Gil Joon Suh4, Woon Yong Kwon4, Jae Hyuk Lee1, Jonghwan Shin5, Inwon Park1, Che Uk Lee1, Sang-Min Lee1.   

Abstract

OBJECTIVE: Metabolic acidosis is commonly associated with the disease severity in patients with sepsis or septic shock. This study was performed to investigate the association between serum total carbon dioxide (TCO2) concentration and 28-day mortality in patients with sepsis.
METHODS: This study was a multicenter retrospective cohort study of patients with sepsis or septic shock. The relationships between serum TCO2 and 28-day mortality, bicarbonate, pH, lactate, and anion gap were determined with cubic spline curves. The patients were divided into four groups according to their serum TCO2 concentration: Group I (TCO2 > 20 mmol/l), Group II (15 < TCO2 ≤ 20 mg/dl), Group III (10 < TCO2 ≤ 15 mmol/l), and Group IV (TCO2 ≤ 10 mmol/l).
RESULTS: A total of 3168 patients were included in the analysis, and the overall mortality rate was 24.1%. Serum TCO2 concentrations below 20 mmol/l showed an almost linear correlation with mortality as well as with lactate, bicarbonate, and pH. The 28-day mortality rates of Group I, II, III, and IV were 18.3%, 23.6%, 32.6%, and 50.0%, respectively (p < .001). In Multivariable Cox proportional hazard regression analysis, the groups with lower serum TCO2 concentrations had a higher risk of 28-day mortality compared with Group I: Group II (Hazard ratio (HR), 1.35; 95% confidence interval (CI), 1.11-1.64), Group III (HR, 1.74; 95% CI, 1.37-2.21), and Group IV (HR, 2.72; 95% CI, 2.03-3.64).
CONCLUSIONS: Serum TCO2 concentrations of 20 mmol/l or less were associated with 28-day mortality in patients with sepsis.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acidosis; Carbon dioxide; Mortality; Prognosis; Sepsis

Year:  2020        PMID: 32303411     DOI: 10.1016/j.ajem.2020.04.006

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  1 in total

1.  TaibUVID nutritional supplements help rapid cure of COVID-19 infection and rapid reversion to negative nasopharyngeal swab PCR: for better public prophylaxis and treatment of COVID-19 pandemic.

Authors:  Salah Mohamed El Sayed; Moutasem Salih Aboonq; Yasmeen Talal Aljehani; Mohammad Ahmad Hassan; Rabab M Abou El-Magd; Abdelrahman I Abdelrahman; Rehab El-Tahlawi; Manal Mohamed Helmy Nabo; Reda S Yousef; Ahmed Alamir Mahmoud; Yasser Yahia Elsayed; Mostafa Abu-Elnaga; Tamer M Soliman; Abdelhady Ragab Abdel-Gawad; Momen Elshazley; Hussam Baghdadi; Samer El-Sawy; Hany Salah Mahmoud; Mariam E El-Anzi; Mansour Barakah Alharbi
Journal:  Am J Blood Res       Date:  2020-12-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.